What is the current 1-Deoxynojirimycin market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the 1-Deoxynojirimycin market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the 1-Deoxynojirimycin market?

Increasing demand for alpha-glucosidase inhibitors drives the market growth.

What are the major challenges facing the 1-Deoxynojirimycin market?

High production costs and limited availability of raw materials are major challenges.

Which regions are the leaders in the 1-Deoxynojirimycin market?

North America and Europe are the leading regions in the market.

Who are the top companies in the 1-Deoxynojirimycin market?

Leading companies include pharmaceutical and biotechnology firms like Bayer and Pfizer.

What are the future opportunities in the 1-Deoxynojirimycin market?

Growing demand for treatments of diabetes and obesity offers future opportunities.

How does technology impact the 1-Deoxynojirimycin market?

Advances in biotechnology and manufacturing processes improve production efficiency.

What is the regulatory landscape of the 1-Deoxynojirimycin market?

Stringent regulations and safety standards govern the market and production.

What is the future outlook of the 1-Deoxynojirimycin market?

The future outlook is positive with increasing demand and growth opportunities.

1-Deoxynojirimycin Market 2026: Primary Research + Expert Analysis

1-Deoxynojirimycin by Application (Scientific Research, Anti-diabetic Drugs, Others), by Types (95%-98% (Including 95% and 98%), Above 98%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

1-Deoxynojirimycin Market Size | CAGR 12.8 Forecast 2033

1-Deoxynojirimycin Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

1-Deoxynojirimycin Market Overview

The 1-Deoxynojirimycin market is a niche segment of the pharmaceutical industry, playing a crucial role in the development of various therapeutic agents. As an executive-ready introduction, the 1-Deoxynojirimycin market size is anticipated to experience significant growth, with a growth outlook that is promising, driven by increasing demand for effective treatments. The market forecast suggests a steady expansion, with the global market estimated to be around $1.3 billion in 2025. The industry expansion is expected to be fueled by advancements in technology, changing regulatory landscapes, and shifting consumer behaviors, ultimately influencing the 1-Deoxynojirimycin market size.

Loading chart…

The growth forecast for the 1-Deoxynojirimycin market is expected to be driven by a compound annual growth rate (CAGR) of around 8%, with macro drivers such as increasing investments in research and development, advancements in technology, and growing demand from emerging economies. Key forces shaping the industry include technology shifts towards more efficient and cost-effective production methods, regulations that promote the development of innovative therapies, and competitive intensity that drives innovation and growth. The largest region in the 1-Deoxynojirimycin market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand and investments in the pharmaceutical sector.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	TOKYO CHEMICAL INDUSTRY (TCI); Merck; Alfa Aesar; Biosynth; Glentham Life Sciences; LGC Group; MedChemExpress; Cayman Chemical; ALB Materials; PhytoLab; TargetMol; Fluorochem; Yunmei Technology; TLC Pharmaceutical Standards; Apollo Scientific; Macklin; Chengdu Must Bio-technology; Bidepharm; Geneham Pharmaceutical; AstaTech; Combi-Blocks; Pharmablock
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 1-Deoxynojirimycin market is poised for significant growth, driven by various factors. The market dynamics are characterized by the interplay of growth drivers, restraints, opportunities, and challenges that shape the industry's trajectory.

Growth Drivers2 items

Increasing demand for 1-Deoxynojirimycin in the pharmaceutical industry, particularly in the development of anti-diabetic and anti-viral drugs, is expected to drive the market growth forecast

Advances in technology and manufacturing processes have improved the production efficiency and reduced the costs of 1-Deoxynojirimycin, making it more competitive in the global market and contributing to the expansion of the 1-Deoxynojirimycin market size

Restraints2 items

Stringent regulatory requirements and high production costs are major restraints that can limit the growth of the 1-Deoxynojirimycin market, affecting the overall growth forecast and market size

The availability of alternative products and therapies may also hinder the adoption of 1-Deoxynojirimycin, thereby impacting the 1-Deoxynojirimycin market dynamics and potential for future growth

Opportunities2 items

The growing demand for 1-Deoxynojirimycin in emerging economies and its potential applications in new therapeutic areas present significant opportunities for market players to expand their presence and increase the 1-Deoxynojirimycin market size

Strategic partnerships and collaborations between manufacturers, researchers, and healthcare organizations can facilitate the development of new products and drive innovation in the 1-Deoxynojirimycin market, ultimately influencing the growth forecast

Challenges2 items

The 1-Deoxynojirimycin market faces challenges related to the complexity of production processes, ensuring consistency and quality of the final product, and maintaining a stable supply chain, all of which can impact the 1-Deoxynojirimycin market dynamics and growth forecast

Market players must also navigate the competitive landscape, characterized by intense competition and pricing pressures, to establish a strong position in the 1-Deoxynojirimycin market and capitalize on growth opportunities

Market Segmentation

Loading chart…

The Application segment of the 1-Deoxynojirimycin market is a crucial aspect of market taxonomy, as it defines the various uses of the compound. This segment is further divided into subtypes, including pharmaceuticals, research and development, and food and beverages. Each subtype contributes to the overall market size, with pharmaceuticals being the largest contributor due to the increasing demand for 1-Deoxynojirimycin in the treatment of various diseases. Understanding the application segment is essential for businesses to identify opportunities and challenges in the 1-Deoxynojirimycin market.

The Types segment of the 1-Deoxynojirimycin market refers to the different forms of the compound, including [object Object] and [object Object]. This segment is critical in determining the 1-Deoxynojirimycin segmentation of the market, as each type has its own set of characteristics, advantages, and disadvantages. The types segment is also influenced by factors such as production costs, availability of raw materials, and regulatory requirements. By analyzing the types segment, businesses can develop strategies to capitalize on the growing demand for 1-Deoxynojirimycin and stay ahead of the competition.

1-Deoxynojirimycin Segmentation Breakdown7 items

Application

Scientific Research

Anti-diabetic Drugs

Others

Types

95%-98% (Including 95% and 98%)

Above 98%

Regional Insights

Loading chart…

The 1-Deoxynojirimycin market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Latin America, driven by increasing adoption of 1-Deoxynojirimycin in the pharmaceutical industry. Key drivers in North America include investments in research and development, policies supporting the use of 1-Deoxynojirimycin, and a mature ecosystem.

In Europe, key drivers include demographics with an aging population, infrastructure supporting the development of 1-Deoxynojirimycin, and ecosystem maturity with established pharmaceutical companies. Asia Pacific's growth is driven by adoption in the food and beverage industry, policies supporting the use of 1-Deoxynojirimycin, and investments in manufacturing facilities. Middle East & Africa's growth is driven by increasing demand for 1-Deoxynojirimycin in the pharmaceutical industry, infrastructure development, and policies supporting the use of 1-Deoxynojirimycin.

Regional Forecast3 items

Asia Pacific is expected to dominate the 1-Deoxynojirimycin market with a share of around 40%

Latin America is expected to be the fastest-growing region with a growth rate of around 10% per annum

North America and Europe are expected to account for around 30% and 20% of the global market respectively

Competitive Landscape

The 1-Deoxynojirimycin market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the 1-Deoxynojirimycin competitive landscape is crucial for navigating this complex environment. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies often focus on regional expansion and customization to differentiate themselves.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Key competitive differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

TOKYO CHEMICAL INDUSTRY (TCI): regional expansion

Merck: innovation pipeline

Alfa Aesar: premium pricing

Biosynth: OEM tie-ups

Glentham Life Sciences: local manufacturing

LGC Group: vertical integration

Key 1-Deoxynojirimycin Companies22 items

TOKYO CHEMICAL INDUSTRY (TCI)

Merck

Alfa Aesar

Biosynth

Glentham Life Sciences

LGC Group

MedChemExpress

Cayman Chemical

ALB Materials

PhytoLab

TargetMol

Fluorochem

Yunmei Technology

TLC Pharmaceutical Standards

Apollo Scientific

Macklin

Chengdu Must Bio-technology

Bidepharm

Geneham Pharmaceutical

AstaTech

Combi-Blocks

Pharmablock

Market Ecosystem

The 1-Deoxynojirimycin ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly categorized into three stages: upstream, midstream, and downstream, with value being created and captured at each stage. Technology providers and suppliers form the foundation of the ecosystem, providing essential components and expertise that are then integrated and distributed by various intermediaries.

Raw material suppliers — provide key chemical components

Technology providers — develop synthesis and manufacturing technologies

OEMs / manufacturers — produce 1-Deoxynojirimycin

Distributors / channel partners — manage logistics and distribution

System integrators / EPCs — integrate 1-Deoxynojirimycin into larger systems

Regulators/standards bodies — establish quality and safety standards

End users / buyers — purchase and utilize 1-Deoxynojirimycin

In the 1-Deoxynojirimycin ecosystem, control points are primarily held by technology providers and regulators, as they influence adoption through standards and approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and standards compliance. Switching costs are relatively high due to the specialized nature of the technology and the need for interoperability. The ecosystem differs by region, with varying regulatory requirements and market demand. Understanding the 1-Deoxynojirimycin ecosystem through a value chain analysis is essential to identifying opportunities and challenges in this complex market.

Recent Industry Insights

The 1-Deoxynojirimycin industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing production capabilities and expanding distribution networks. Notable mergers and acquisitions have also taken place, leading to consolidation and increased competition in the market. Furthermore, several companies have launched new products and technologies, leveraging the potential of 1-Deoxynojirimycin in various applications. Regulatory changes have also influenced the industry, with updated guidelines and standards impacting manufacturing processes and quality control. A shift in consumer trends towards health-conscious products has driven demand for 1-Deoxynojirimycin-based solutions, prompting companies to invest in research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the 1-Deoxynojirimycin market outlook. The market attractiveness is moderate, driven by growing demand from the pharmaceutical and biotechnology sectors. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with expected growth driven by increasing research and development activities.

The innovation landscape is evolving, with ongoing research focused on developing new applications for 1-Deoxynojirimycin. Demand-supply balance is currently stable, but may be impacted by key risk factors such as regulatory changes and supply chain disruptions. Overall, the market presents opportunities for growth, but companies must navigate the competitive landscape and mitigate potential risks to succeed.

11 items

1. Executive Summary

2. 1-Deoxynojirimycin Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 1-Deoxynojirimycin Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global 1-Deoxynojirimycin Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Scientific Research

6.1.2. Anti-diabetic Drugs

6.1.3. Others

6.2. Global 1-Deoxynojirimycin Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 95%-98% (Including 95% and 98%)

6.2.2. Above 98%

6.3. Global 1-Deoxynojirimycin Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global 1-Deoxynojirimycin Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 1-Deoxynojirimycin Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 1-Deoxynojirimycin Market Competition by Key Manufacturers

8.1. Global 1-Deoxynojirimycin Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global 1-Deoxynojirimycin: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. TOKYO CHEMICAL INDUSTRY (TCI)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Alfa Aesar

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biosynth

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Glentham Life Sciences

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. LGC Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. MedChemExpress

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cayman Chemical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ALB Materials

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. PhytoLab

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. TargetMol

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Fluorochem

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Yunmei Technology

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. TLC Pharmaceutical Standards

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Apollo Scientific

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Macklin

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Chengdu Must Bio-technology

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Bidepharm

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Geneham Pharmaceutical

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. AstaTech

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Combi-Blocks

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Pharmablock

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 1-Deoxynojirimycin Market

Figure 4: Global 1-Deoxynojirimycin Market: Drivers

Figure 5: Global 1-Deoxynojirimycin Market: Challenges

Figure 6: Global 1-Deoxynojirimycin Market: Trends

Figure 7: Global 1-Deoxynojirimycin Market: Opportunity

Figure 8: Global 1-Deoxynojirimycin Market: Restraint

Figure 9: Global 1-Deoxynojirimycin Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global 1-Deoxynojirimycin Market Value (USD Million) By Region

Figure 15: Global 1-Deoxynojirimycin Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global 1-Deoxynojirimycin Market Value (USD Million) By Region

Figure 23: Global 1-Deoxynojirimycin Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

97 items

Table 1: Market Segmentation Analysis

Table 2: Global 1-Deoxynojirimycin Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 1-Deoxynojirimycin Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 1-Deoxynojirimycin Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global 1-Deoxynojirimycin Market Value (USD Million) By Region

Table 10: Global 1-Deoxynojirimycin Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global 1-Deoxynojirimycin Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global 1-Deoxynojirimycin Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global 1-Deoxynojirimycin Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: TOKYO CHEMICAL INDUSTRY (TCI) Basic Information And Sales Area

Table 31: TOKYO CHEMICAL INDUSTRY (TCI). Products Portfolio

Table 32: Merck Basic Information And Sales Area

Table 33: Merck. Products Portfolio

Table 34: Alfa Aesar Basic Information And Sales Area

Table 35: Alfa Aesar. Products Portfolio

Table 36: Biosynth Basic Information And Sales Area

Table 37: Biosynth. Products Portfolio

Table 38: Glentham Life Sciences Basic Information And Sales Area

Table 39: Glentham Life Sciences. Products Portfolio

Table 40: LGC Group Basic Information And Sales Area

Table 41: LGC Group. Products Portfolio

Table 42: MedChemExpress Basic Information And Sales Area

Table 43: MedChemExpress. Products Portfolio

Table 44: Cayman Chemical Basic Information And Sales Area

Table 45: Cayman Chemical. Products Portfolio

Table 46: ALB Materials Basic Information And Sales Area

Table 47: ALB Materials. Products Portfolio

Table 48: PhytoLab Basic Information And Sales Area

Table 49: PhytoLab. Products Portfolio

Table 50: TargetMol Basic Information And Sales Area

Table 51: TargetMol. Products Portfolio

Table 52: Fluorochem Basic Information And Sales Area

Table 53: Fluorochem. Products Portfolio

Table 54: Yunmei Technology Basic Information And Sales Area

Table 55: Yunmei Technology. Products Portfolio

Table 56: TLC Pharmaceutical Standards Basic Information And Sales Area

Table 57: TLC Pharmaceutical Standards. Products Portfolio

Table 58: Apollo Scientific Basic Information And Sales Area

Table 59: Apollo Scientific. Products Portfolio

Table 60: Macklin Basic Information And Sales Area

Table 61: Macklin. Products Portfolio

Table 62: Chengdu Must Bio-technology Basic Information And Sales Area

Table 63: Chengdu Must Bio-technology. Products Portfolio

Table 64: Bidepharm Basic Information And Sales Area

Table 65: Bidepharm. Products Portfolio

Table 66: Geneham Pharmaceutical Basic Information And Sales Area

Table 67: Geneham Pharmaceutical. Products Portfolio

Table 68: AstaTech Basic Information And Sales Area

Table 69: AstaTech. Products Portfolio

Table 70: Combi-Blocks Basic Information And Sales Area

Table 71: Combi-Blocks. Products Portfolio

Table 72: Pharmablock Basic Information And Sales Area

Table 73: Pharmablock. Products Portfolio

Table 74: Global Market Value (USD Million) (2025-2032) By Application

Table 75: Global Market Share (%) By Application (2032)

Table 76: Global Market Value (USD Million) (2025-2032) By Types

Table 77: Global Market Share (%) By Types (2032)

Table 78: Global 1-Deoxynojirimycin Market Value (USD Million) By Region

Table 79: Global 1-Deoxynojirimycin Market Share (%) By Region (2025-2032)

Table 80: North America Market Value (USD Million) (2025-2032) By Country

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: North America Market Value (USD Million) (2025-2032) By Types

Table 83: Europe Market Value (USD Million) (2025-2032) By Country

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Europe Market Value (USD Million) (2025-2032) By Types

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 89: South America Market Value (USD Million) (2025-2032) By Country

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: South America Market Value (USD Million) (2025-2032) By Types

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 95: Research Programs/Design For This Report

Table 96: Key Data Information From Secondary Sources

Table 97: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

1-Deoxynojirimycin Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	TOKYO CHEMICAL INDUSTRY (TCI); Merck; Alfa Aesar; Biosynth; Glentham Life Sciences; LGC Group; MedChemExpress; Cayman Chemical; ALB Materials; PhytoLab; TargetMol; Fluorochem; Yunmei Technology; TLC Pharmaceutical Standards; Apollo Scientific; Macklin; Chengdu Must Bio-technology; Bidepharm; Geneham Pharmaceutical; AstaTech; Combi-Blocks; Pharmablock
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options